I heard back from Scantibodies in California who confirmed they do not to the sAg testing for individuals. I'm reaching out to India today and still have not heard back from the lab in Los Algodones, Mexico. Also thinking about reaching out to some well known liver centers in the USA to see if just maybe there's a chance I can get this done in my country instead of having to ship blood out of the country.
Does anybody have any idea how much work that would be? I'm assuming the blood needs to be have dry ice with it and be overnighted?
Forget about ARC now...right now you need to focus on getting your HBsAg results done, and do that asap.
You must remember though that people had unrealistic expectations of a 1-2mg/kg dose. That's not going to do a ton - a 50% knockdown from that is pretty darn good. It was also a single dose - the trials now going on involve multi-dose cohorts I believe. Plus, on AD we'll get the data from the higher dose studies.
It could crash and burn and honestly that's probably the best thing to assume right now to not get hopes up.
Well still investors to secure their investment they definitely need a progress from the trials. I know last time they had a big problem with big investors due to false promises they provided them & hope this time 'll not happen.
ARC-520 is just for investors, the effect on hbsag was so little, only replicor has shown to make it und by few weeks and you bet replicor has been sabotaged...zero investors and no big pharma to buy this small company
Wonder if they'll find a way to sabotage/not approve the new clinical stuff like ARC-520. There's some evidence to suggest it has really good sAg KD rates (50%) after a single 1-2mg/kg dose. Seems like that would really cut into antiviral profits.